| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs umeclidinium bromide (a long-acting muscarinic antagonist, or LAMA) with vilanterol (LABA); and TRELEGY ELLIPTA, a comprehensive treatment …
Over the last 12 months, insiders at Innoviva, Inc. have bought $0 and sold $0 worth of Innoviva, Inc. stock.
On average, over the past 5 years, insiders at Innoviva, Inc. have bought $8.5M and sold $14.27M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 62,000 shares for transaction amount of $814,196 was made by DENNER ALEXANDER J (10 percent owner) on 2023‑06‑15.
| 2025-03-06 | Sale | DENNER ALEXANDER J | 10 percent owner | 1.2M 1.9005% | $17.52 | $20.96M | +11.14% | |
| 2025-03-05 | Sale | DENNER ALEXANDER J | 10 percent owner | 270,374 0.4315% | $17.63 | $4.77M | +10.96% | |
| 2025-03-04 | Sale | DENNER ALEXANDER J | 10 percent owner | 151,175 0.2411% | $17.63 | $2.67M | +11.10% | |
| 2023-11-15 | Sale | Zhen Marianne | Chief Accounting Officer | 10,994 0.0173% | $13.99 | $153,810 | +16.83% | |
| 2023-06-15 | DENNER ALEXANDER J | 10 percent owner | 62,000 0.0912% | $13.13 | $814,196 | +11.09% | ||
| 2023-06-06 | DENNER ALEXANDER J | 10 percent owner | 8,000 0.0118% | $13.05 | $104,384 | +10.41% | ||
| 2023-06-05 | DENNER ALEXANDER J | 10 percent owner | 7,000 0.0102% | $13.04 | $91,297 | +9.05% | ||
| 2023-05-30 | DENNER ALEXANDER J | 10 percent owner | 120,000 0.1775% | $13.01 | $1.56M | +7.09% | ||
| 2023-05-26 | DENNER ALEXANDER J | 10 percent owner | 30,000 0.0442% | $13.12 | $393,729 | +5.48% | ||
| 2023-05-25 | DENNER ALEXANDER J | 10 percent owner | 50,000 0.0735% | $13.09 | $654,330 | +5.48% | ||
| 2023-05-19 | DENNER ALEXANDER J | 10 percent owner | 36,000 0.0531% | $13.48 | $485,147 | +1.63% | ||
| 2023-05-18 | DENNER ALEXANDER J | 10 percent owner | 10,000 0.0146% | $13.05 | $130,538 | +3.71% | ||
| 2023-05-17 | DENNER ALEXANDER J | 10 percent owner | 50,000 0.0736% | $13.07 | $653,690 | +4.39% | ||
| 2023-05-11 | DENNER ALEXANDER J | 10 percent owner | 290,000 0.4246% | $12.34 | $3.58M | +9.81% | ||
| 2023-03-10 | Raifeld Pavel | Chief Executive Officer | 3,000 0.0045% | $10.87 | $32,603 | +22.61% | ||
| 2021-08-20 | Sale | Zhen Marianne | Chief Accounting Officer | 1,129 0.0016% | $15.89 | $17,940 | +3.07% | |
| 2021-08-19 | Sale | Zhen Marianne | Chief Accounting Officer | 2,802 0.004% | $16.02 | $44,888 | +2.50% | |
| 2021-05-24 | Bickerstaff George | director | 10,000 0.0112% | $13.46 | $134,619 | +21.34% | ||
| 2021-05-21 | Bickerstaff George | director | 10,000 0.0111% | $12.97 | $129,670 | +24.75% | ||
| 2021-05-20 | Sale | GLAXOSMITHKLINE PLC | 10 percent owner | 32.01M 33.288% | $12.25 | $392.06M | +23.35% |
| DENNER ALEXANDER J | 10 percent owner | 5658705 7.8326% | $118.44M | 10 | 3 | +6.82% |
| Winningham Rick E | Chief Executive Officer | 690106 0.9552% | $14.44M | 1 | 10 | +19.7% |
| Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 446274 0.6177% | $9.34M | 1 | 9 | <0.0001% |
| GLICK MARTY | Executive VP, Finance and CFO | 267805 0.3707% | $5.61M | 1 | 0 | <0.0001% |
| BLUM LEONARD M | Sr VP, Chief Comm. Officer | 158618 0.2196% | $3.32M | 3 | 0 | +41.61% |
| Bickerstaff George | director | 124560 0.1724% | $2.61M | 4 | 0 | +6.52% |
| VAGELOS P ROY | director | 71499 0.099% | $1.5M | 2 | 0 | +22.34% |
| Humphrey Patrick PA | Executive VP Research | 11000 0.0152% | $230,230.00 | 1 | 0 | <0.0001% |
| Raifeld Pavel | Chief Executive Officer | 9799 0.0136% | $205,093.07 | 1 | 0 | +22.61% |
| HULME GEOFFREY | Interim PEO | 7000 0.0097% | $146,510.00 | 1 | 0 | <0.0001% |
| Sturmer A Gregory | Vice President Finance | 290 0.0004% | $6,069.70 | 1 | 0 | <0.0001% |
| GLAXOSMITHKLINE PLC | 10 percent owner | 0 0% | $0 | 9 | 1 | +1.07% |
$8,217,280 | 112 | 46.33% | $1.6B | |
$54,660,406 | 66 | 22.24% | $1.5B | |
Innoviva, Inc. (INVA) | $530,111,731 | 35 | 8.69% | $1.51B |
$27,136,525 | 32 | 36.73% | $1.64B | |
$4,431,947 | 22 | 36.10% | $1.46B |
| Increased Positions | 151 | +52.61% | 8M | +10.58% |
| Decreased Positions | 124 | -43.21% | 8M | -10.97% |
| New Positions | 45 | New | 2M | New |
| Sold Out Positions | 31 | Sold Out | 1M | Sold Out |
| Total Postitions | 314 | +9.41% | 76M | -0.39% |
| Blackrock, Inc. | $187,509.00 | 12.58% | 9.44M | +320,395 | +3.51% | 2025-09-30 |
| Vanguard Group Inc | $141,024.00 | 9.46% | 7.1M | -81,916 | -1.14% | 2025-09-30 |
| Renaissance Technologies Llc | $91,142.00 | 6.12% | 4.59M | -173,900 | -3.65% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $86,044.00 | 5.77% | 4.33M | +35,960 | +0.84% | 2025-09-30 |
| Sarissa Capital Management Lp | $55,954.00 | 3.76% | 2.82M | 0 | 0% | 2025-09-30 |
| State Street Corp | $50,807.00 | 3.41% | 2.56M | +99,510 | +4.05% | 2025-09-30 |
| Franklin Resources Inc | $49,631.00 | 3.33% | 2.5M | -330,137 | -11.67% | 2025-09-30 |
| Arrowstreet Capital, Limited Partnership | $46,866.00 | 3.15% | 2.36M | +650,151 | +38.05% | 2025-09-30 |
| American Century Companies Inc | $46,714.00 | 3.14% | 2.35M | +284,253 | +13.75% | 2025-09-30 |
| Systematic Financial Management Lp | $42,052.00 | 2.82% | 2.12M | +57,190 | +2.78% | 2025-09-30 |